These work by mimicking the effects of a GLP-1 hormone that regulates blood sugar levels by stimulating insulin release and reducing glucose production in the liver
He was the first to suggest that the disease was caused not only by insulin deficiency, which hindered the removal of glucose from blood, but also a rise in glucagon which increased glucose production
The theoretical rationale for combining them, while intriguing, remains purely speculative without rigorous scientific investigation
Retatrutide is an investigational triple agonist acting on GLP-1, GIP, and glucagon receptors a mechanism distinct from approved agents such as semaglutide or tirzepatide
However, you might experience skin itching, stomach fullness, fast heartbeat, and difficulty breathing or swallowing